Hæmatologi

This thoroughly revised and updated case-based book describes a variety of clinical scenarios in transfusion medicine likely to be encountered in a busy teaching hospital. It highlights the stream of clinical and laboratory data available to transfusionists, while reviewing the critical thinking required to lead the decision-making process towards accurate diagnosis and appropriate management.Transfusion Medicine: Case Studies and Clinical Management is a lively illustration of various clinical problems in transfusion medicine, including immune complications, microbiological problems, blood component use, apheresis techniques and management of complex situations, such as multiple trauma, sickle cell crisis and organ transplantation. Each case is carefully chosen and presented, with incorporated questions leading the reader towards solution of the problem in a logical and didactic manner. It is therefore essential reading for all medical and scientific professionals involved in managing transfusion, from hematologists to obstetricians, surgeons, intensivists and immunologists.

This book describes intraoperative flow cytometry in solid tumours. Intraoperative flow cytometry is an innovative technique for assessing tumour margins and grade of malignancy intraoperatively. The authors have been working on this procedure for more than 14 years and have introduced it in the surgery of intracranial tumours, breast cancer, liver cancer and head and neck neoplasms, as described in the book. A detailed description of the main pathological findings will be followed by an explanation of the intraoperative flow cytometry¿s role. In each chapter, information will be provided to stimulate further research on this topic. The book will also include new topics that have not been published till now.The book is aimed at neurosurgeons, general surgeons, ENT specialists, breast surgeons, radiologists, pathologists, oncologists, biologists, biochemists and scientists working with on flow cytometry.

This book provides a comprehensive overview of multiple myeloma. It is organized into three sections with chapters addressing topics such as diagnosis, risk stratification, and management of multiple myeloma; treatment of multiple myeloma at diagnosis and at relapse; management of disease complications; and stem cell therapies, including autologous and allogeneic hematopoietic stem cell transplantation with a focus on autologous grafting using non-cryopreserved stem cells and performance of stem cell transplantation in outpatient settings.

Dieses Buch ist eine Open-Access-Publikation unter einer Creative Commons Attribution International License (CC BY 4.0).Bewährt und einfach zu handhaben: praxisorientierte Sammlung von Chemotherapie-Protokollen zur Behandlung von Tumorpatienten mit soliden und hämatologischen Erkrankungen. Auf einen Blick finden sich Detailinformationen zu den unterschiedlichen Chemotherapien, möglichen Nebenwirkungen, empfohlener Begleitmedikation, supportiven Therapien, notwendigen Kontrollen, Zusatzinformationen für eine sichere Applikation sowie möglichen Notfallsituationen. Das Buch richtet sich an behandelnde Ärztinnen und Ärzte, Pflegende, Apothekerinnen und Apotheker und alle Tumortherapie-Interessierte.Aus dem InhaltÜber 600 umfassend ausgearbeitete und jahrelang in der Praxis etablierte Behandlungsprotokolle, übersichtlich nach Tumorentitäten und Indikationen geordnet.Behandlung von hämatologischen Neoplasien, soliden Tumoren, inkl. Protokolle der kooperierenden Bereiche Gynäkologie, Gastroenterologie, Radioonkologie, Dermatologie, Urologie und Neuroonkologie.Mobilisierungs-Chemotherapien, autologe Konditionierung, allogene Konditionierung, Lymphodepletion vor CAR-T-Zelltherapie, bispezifische Antikörper- und andere Immuntherapien, GvHD-Prophylaxe, supportive Therapie und intrakavitäre Chemotherapien.Neu in der 8. Auflage: Umfangreiche Protokollneuerungen, u.a. in den Bereichen AML und Gynäkologie, Protokolle zur Lymphodepletion vor CAR-T-Zelltherapie, Dosismodifikationstabelle bei Leber- und Nierenfunktionsstörungen komplett überarbeitet mit QuellenangabePlus: Chemotherapieprotokolle und detaillierte Kurvenblätter, SOPs und Clinical Pathways sowie Patienteninformationen als elektronisches Zusatzmaterial zum Download auf SpringerLink. Die HerausgeberProf. Dr. Monika Engelhardt, Klinik für Innere Medizin I, Schwerpunkt Hämatologie, Onkologie und Stammzelltransplantation, Universitätsklinikum Freiburg, DeutschlandProf. Dr. Dr. h.c. Roland Mertelsmann, Klinik für Innere Medizin I, Schwerpunkt Hämatologie, Onkologie und Stammzelltransplantation, Universitätsklinikum Freiburg, DeutschlandProf. Dr. Justus Duyster, Klinik für Innere Medizin I, Schwerpunkt Hämatologie, Onkologie und Stammzelltransplantation, Universitätsklinikum Freiburg, Deutschland

Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, Fourth Edition continues to be the only "pocket-size" quick reference for pathology and transfusion medicine for residents and fellows. It is helpful to all physicians and allied health professionals who order and administer blood components, cellular therapies, specialized factors for hemostatic abnormalities, coagulation testing, and those who consult and care for these often very ill patients. This book is ideal for pathology, medicine, surgery, and anesthesia residents, transfusion, hematology, and anesthesia fellows, and certified and specialized practitioners, as well as medical technologist in transfusion, cellular therapy, hematology, and coagulation. This new edition covers the many new developments that have occurred since the previous edition to include new blood products, new indications, or clinical conditions in which blood products are used. Similarly, new hemostasis testing is introduced as well as new clinical scenarios due the COVID-19 pandemic that area relevant to hemostasis and transfusion medicine. This includes COVID coagulopathy, Vaccine Induced Thrombotic Immune Thrombocytopenia, Pediatric reference range in coagulation testing, Platelet rich plasma and MNC products - CAR-T cells.

Learn about all things lymphatic health with this handy guide packed with information, advice, and strategies to increasing longevity, mastering lymphatic drainage massage, and maintaining total-body health.The lymphatic system functions as a maintenance department for the body. It controls the fluid levels in our tissues, plays an important role in the optimal performance of immune responses, and aids the production of cells and antibodies that protects us from viruses and diseases. In this Book You will learn..Eliminate inflammationIncrease energyMaintain a healthy glowImprove immune healthStep-by-step lymphatic drainage massage techniques and their benefitsSimple, healthy recipesAnd much more!This book is intended to provide information on the value of the lymphatic system to the overall body conditions. Learn about ways to optimize your health and energy by keeping your lymphatic system healthy!

This book presents the clinical scope of cancer immunotherapeutic agents for solid tumors and Hematologic malignancies, elaborates on the scientific details of their modes of action, and presents the impact of these agents on oncology, patients and the broader healthcare system. At present, cancer immunotherapies fall broadly into three categories: immune checkpoint inhibitors (ICIs), adoptive T cell therapies, and cancer vaccines which have distinct mechanisms of action. Immune checkpoint inhibitors rely upon disrupting tumor antigen recognition as self by the immune system through inhibition of checkpoint molecules. Adoptive T cell therapies involve the engineering of T cells ex vivo to target and destroy tumor cells.The first part of this book will provide an overview of the discovery and mechanistic details of the technology. The second part will be devoted to elaborating on the clinical outcomes, successes and limitations for specific tumor subtypes, which includes both solid tumors and hematologic malignances for both pediatric and adult populations. As such, the book offers a valuable resource for oncologists, hematologists, and all those seeking an up-to-date overview of cancer immunotherapies.

In this issue of Hematology/Oncology Clinics, guest editors Drs. Bradley A. McGregor and Toni K. Choueiri bring their considerable expertise to the topic of Renal Cell Cancer. Top experts in the field cover key topics such as VHL and HIF at the center of renal cell cancer biology; immunobiology and metabolic pathways of renal cell cancer; hereditary renal cell cancer syndromes; the role of the pathologist in renal cell cancer; novel imaging in renal cell cancer; and more. Contains 18 relevant, practice-oriented topics including the role of surgery in metastatic renal cell cancer; emerging biomarkers in metastatic renal cell cancer; choosing the right treatment for renal cell cancer of variant histology; novel targets in the treatment of renal cell cancer; and more. Provides in-depth clinical reviews on renal cell cancer, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Dr. Richard Polin's Neonatology Questions and Controversies series highlights the toughest challenges facing physicians and care providers in clinical practice, offering trustworthy guidance on up-to-date diagnostic and treatment options in the field. In each volume, renowned experts address the clinical problems of greatest concern to today's practitioners, helping you handle difficult practice issues and provide optimal, evidence-based care to every patient.The thoroughly updated, full-color, 4th Edition of Hematology and Transfusion Medicine:  Provides a clear management strategy for complications in premature infants resulting from hematologic and immunologic systems that are not yet fully developed, offering guidance based on the most up-to-date understanding of underlying pathophysiology.  Places emphasis on controversial areas that can entail different approaches.  Features the most current clinical information throughout, including challenging issues in neonatal hematology such as anemia, transfusions, jaundice, leukocyte counts, and thrombocytopenia.  Includes new chapters on neonatal transfusion medicine, with in-depth evaluations of fetal and neonatal iron homeostasis and risk factors for iron deficiency, and up-to-date information on improvements in bilirubin assessment and management.  Utilizes a consistent chapter organization to help you find information quickly and easily, and contains numerous charts, graphs, radiographic images, and photographs throughout.  Offers the most authoritative advice available from world-class neonatologists who share their knowledge of new trends and developments in neonatal care.  An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.  Purchase each volume individually, or get the entire 7-volume Neonatology Questions and Controversies set, which includes online access that allows you to search across all titles!  Gastroenterology and Nutrition  Hematology and Transfusion Medicine  Neonatal Hemodynamics  Infectious Disease, Immunology, and Pharmacology  Renal, Fluid, and Electrolyte Disorders  Neurology  The Newborn LungÂ

Medical professionals and researchers in the field of leukemias are faced with the need to continuously update their knowledge in a wide range of areas, ranging from fundamental molecular processes and mechanisms to a thorough understanding of clinical features and modern approaches to achieve maximum therapeutic results. This book does not have the ambition to present comprehensively the problems of leukemias, but it is an attempt to acquaint the audience of specialists involved in clinical management and experimental research with some modern advances and concepts in the three main directions: biology, clinical presentation and treatment. The biological aspects of the origin, development and therapy resistance of leukemias are within the scope of the first section. Comprehensive and concise information on the clinical assessment and treatment of leukemia patients is provided, as well as on some specific interdisciplinary clinical scenarios such as leukemic retinopathy, in the second section. Finally, challenges, current standards and recent advances in the therapy of acute leukemias comprise the third section of the book.

In the article "Signaling Modulators in Bone Marrow Microenvironment and HSC Fate," V. P. Kale delves into the intricate signaling mechanisms in the bone marrow microenvironment that regulate the fate of hematopoietic stem cells (HSCs).The author highlights the critical role of various signaling modulators, including cytokines, chemokines, growth factors, and extracellular matrix proteins, in HSC maintenance, proliferation, and differentiation. He also discusses the potential implications of abnormal signaling pathways in HSC fate and the development of hematological disorders such as leukemia.This article is a valuable resource for researchers and clinicians interested in the molecular mechanisms underlying HSC function and the potential therapeutic targets for hematological diseases.

The latest edition of this volume features an extensively revised and expanded collection of immunohematology and transfusion medicine case studies, comprised of clinical vignettes and antibody panels with questions following each case. Arranged in a workbook format, the text presents cases based on real patient problems and covers a number of common issues and challenging problems in blood banking and transfusion practice. Discussion and resolution of each case is provided in a separate answer section, including up-to-date information on pertinent advances in the field. This third edition updates information on existing case chapters and references and adds a variety of new case chapters. The enhanced title of this edition reflects upon the wider array of covered topics, including in-depth case studies of hemostasis and a second section with blood donation and cellular therapy topics. New features include a key to covered topics for each case and a case-difficulty rating scale. Written by experts in the field, Immunohematology, Transfusion Medicine, Hemostasis, and Cellular Therapy: A Case Study Approach, Third Edition is an interactive tool that makes blood banking and transfusion medicine memorable, practical, and relevant to residents, fellows, laboratory technologists, and anyone interested in gaining and updating their knowledge in the field

In this issue of Hematology/Oncology Clinics, guest editors Drs. Jorge J. Castillo, Prashant Kapoor, and Shayna Sarosiek bring their considerable expertise to the topic of Waldenström Macroglobulinemia. Top experts in the field provide a focused update on the biology, diagnosis and management, and novel therapies for patients with Waldenström macroglobulinemia, a rare blood cell cancer characterized by an excess of abnormal white blood cells in the bone marrow. Contains 14 practice-oriented topics including clinical implications of genomic profile in Waldenström macroglobulinemia; chemoimmunotherapy regimens in the frontline management of Waldenström macroglobulinemia; management of relapsed or refractory Waldenström macroglobulinemia; evaluation and management of aggressive transformation in Waldenström macroglobulinemia; management of Waldenström macroglobulinemia in limited-resource settings; and more.  Provides in-depth clinical reviews of Waldenström macroglobulinemia, offering actionable insights for clinical practice.  Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This second edition volume expands on the previous edition with updates about the latest state-of-the-art techniques used in leading hemostasis and thrombosis laboratories for diagnosis and exclusion of hemorrhagic and thrombotic diseases. The chapters in this book are organized into seven parts. Part One provides a general overview on hemostasis and thrombosis, preanalytical issues in testing, and routine hemostasis assays. Part Two covers laboratory testing for thrombophilia, including reviews for activated protein C resistance, protein C, lupus anticoagulant testing, and antiphospholipid antibodies. Part Three addresses monitoring continuous anticoagulant infusions and measuring the effects of oral anti-thrombotic therapy. Part Four talks about heparin induced thrombocytopenia and vaccine induced immune thrombotic thrombocytopenia. Part Five and Six cover ADAMTS13 activity testing and new information on bleeding disorders such as chromogenic factor VIII assays, measurement of emicizumab, and treatment of hemophilia A and B. Finally, Part Seven discusses global assays, research applications, and postanalytical considerations. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.Cutting-edge and comprehensive, Hemostasis and Thrombosis: Methods and Protocols, Second Edition is a valuable resource for scientists and researchers struggling to identify the appropriate methods for hemostasis and thrombosis testing, or who seek additional expert guidance on such testing.

Advances in Oncology reviews the year's most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care. Contains 25 articles on such topics as de-escalation therapy for HPV-associated oropharyngeal cancer; management of in-transit metastatic melanoma; rare gynecologic tumors; pediatric lymphoma: advances with an eye on disparities; the microbiome and CNS tumors; adjuvant therapy for patients with high-risk urothelial cancer following surgery; targeting the RAS gene for treatment of GI cancers; and more. Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice. Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

Dieses Buch bietet einen umfassenden Überblick über die aktuellen Behandlungsstrategien bei indolenten Lymphomen, deren klinische Behandlung den Allgemeinonkologen trotz der enormen Fortschritte bei der Diagnose, der Bewertung von Risikofaktoren und molekularen zielgerichteten Ansätzen weiterhin vor große Herausforderungen stellt. Experten auf diesem Gebiet aus aller Welt beschreiben die Histomorphologie in klinisch relevanter Weise, gehen detailliert auf die Rolle der Risikofaktoren ein und erörtern das gesamte Spektrum der therapeutischen Ansätze. Besonderer Wert wird auf die Umsetzung molekularwissenschaftlicher Erkenntnisse in die klinische Versorgung gelegt, und für jede Entität wird ein krankheitsspezifischer Algorithmus vorgeschlagen. Behandelt werden das follikuläre Lymphom, das MALT-Lymphom, das nodale Marginalzonen-Lymphom, das Milz-Marginalzonen-Lymphom, die Waldenström-Makroglobulinämie, die Haarzell-Leukämie, die chronische lymphatische Leukämie, die Mycosis fungoides, die großkörnige lymphatische Leukämie und auch das Mantelzell-Lymphom. Das Buch ist ein hervorragendes Hilfsmittel für erfahrene und unerfahrene Ärzte gleichermaßen.

Introducing our NHA Phlebotomy Exam Study Guide 2022-2023: Test Prep Book with 400+ Practice Questions for the National Healthcareer Association Certified Phlebotomy Technician Examination [2nd Edition]!Ascencia Test Prep's NHA Phlebotomy Exam Study Guide 2022-2023 includes everything you need to pass the NHA Certified Phlebotomy Technician Examination the first time.Quick review of the concepts covered on the NHA Phlebotomy exam2 full practice tests [1 inside + 1 online] with detailed answer explanationsTips and tricks from experienced phlebotomy techniciansAccess to online flash cards, cheat sheets, and moreAscencia Test Prep's NHA Phlebotomy Exam Study Guide 2022-2023 is aligned with the official National Healthcareer Association Certified Phlebotomy Technician Examination framework. Topics covered include:Anatomy & PhysiologyBlood Specimen CollectionNon-Blood Specimen CollectionSpecimen Handling, Transport, and ProcessingLaboratory OperationsThe National Healthcareer Association was not involved in the creation or production of this product, is not in any way affiliated with Ascencia Test Prep, and does not sponsor or endorse this product.About Ascencia Test PrepAt Ascencia Test Prep, we understand that healthcare professionals need high-quality educational resources. That's why our test prep materials are developed by credentialed experts with years of experience who are excited to share their knowledge with you. Whether you're just starting your career or ready to climb higher, we're here to help you feel ready on test day.

In this issue of Hematology/Oncology Clinics, guest editors Drs. Edward J. Benz, Jr. and Vijay G. Sankaran bring their considerable expertise to the topic of Thalassemia. Top experts in the field provide an overview of the history, epidemiology, pathogenic mechanisms, and clinical management of the thalassemia syndromes. Contains 16 practice-oriented topics including molecular basis and genetic modifiers of thalassemia; fetal hemoglobin in thalassemia; clinical complications and their management; iron chelation in thalassemia; fertility and pregnancy in women with transfusion-dependent thalassemia; gene therapy and genome editing in thalassemia; emerging medical therapies for thalassemia; and more.  Provides in-depth clinical reviews on thalassemia, offering actionable insights for clinical practice.  Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

ABC of Clinical HaematologyAn essential guide and introduction to the diagnosis, treatment and management of disorders across the breadth of clinical haematologyExtensively revised, this 5th edition of ABC of Clinical Haematology covers all aspects of contemporary haematology, providing the basic science behind the disease and diagnostic aspects, along with up to date management. The text assumes little prior haematology knowledge, enabling clear understanding by non-experts, including medical students and nurses. Full colour illustrations and text boxes highlighting important learning points together enable more efficient reader comprehension.ABC of Clinical Haematology covers:* Iron deficiency anaemia, macrocytic anaemia, hereditary anaemias, polycythaemia vera, essential thrombocythaemia, and myelofibrosis* Chronic myeloid leukaemia, acute leukaemias, lymphoma, stem cell transplantation, cellular therapies, adult myelodysplastic syndrome, and myeloma* Bleeding disorders, thrombosis, anticoagulation, and paediatric haematology, platelet disorders* Amyloidosis, with focus on systemic light chain amyloidosis, and haematological emergencies* New tests, treatments, and management solutions that are now available for certain conditions, especially common blood related disordersWith contributions from leading experts in their respective fields, ABC of Clinical Haematology, Fifth Edition provides an ideal reference for primary care practitioners and other healthcare professionals working with patients who have blood related problems.About the ABC seriesThe ABC series has been designed to help you access information quickly and deliver the best patient care, and remains an essential reference tool for GPs, junior doctors, medical students and healthcare professionals.Now offering over 80 titles, this extensive series provides you with a quick and dependable reference on a range of topics in all the major specialties.The ABC series is the essential and dependable source of up-to-date information for all practitioners and students in primary healthcare.To receive automatic updates on books and journals in your specialty, join our email list. Sign up today at www.wiley.com/email

This book provides a concise update on current understanding of the biology of acute and chronic leukemias and other bone marrow neoplasms, including myelodysplastic and myeloproliferative disorders, and explores new and emerging treatments. There is a particular focus on the molecular abnormalities that are drivers of leukemia and on their detection by modern molecular techniques. Knowledge of the ways in which genomic and metabolic abnormalities in the hematologic neoplasms affect prognosis and treatment decision making is reviewed. Detailed attention is devoted to targeted therapies, including novel drugs, and to potential targets for future drug development. In addition, readers find in-depth discussion of cellular and antibody-based immunotherapies as well as the role of hematopoietic stem cell transplantation in the treatment of leukemias and bone marrow malignancies. The book is of special interest for hematologists, oncologists, and cancer researchers; it is also of value for hematology trainees and medical students.

Extensively revised, comprehensive content from leading global contributors ensures that Hematology, 8th Edition, remains your #1 choice for expert guidance in all areas of this rapidly advancing subspecialty. This edition reflects the numerous advances that are redefining the field and dramatically influencing new approaches to diagnosis, treatment, and outcomes. Well-illustrated and clinically focused, it details the basic science and clinical practice of hematology and hematopoietic cellular therapy-covering virtually all aspects of hematology in one definitive resource. Covers all hematologic disorders, including comprehensive discussions of hematologic malignancies, individualized patient care, cell-based therapies, transplantation, transfusion medicine, hemostasis, thrombosis, and consultative hematology-in one convenient volume. Provides state-of-the-art guidance from global experts at the forefront of the latest research and clinical practice. Provides extensive updates throughout on basic science research, advances in molecular diagnostics, new drugs, immunotherapies, personalized medicine, laboratory medicine, transfusion medicine, stem cell transplantation, and clinical treatment for all hematologic malignancies and non-malignancies Contains new chapters on gene editing; the impact of mitochondria on hematopoiesis; myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes; immunotherapy and management of its toxicities; transfusion medicine in sickle cell disease; principles of radiation therapy; and COVID-19, including complications of vaccination and its impact on the hematologic system. Discusses many new advances in the field, including details and the future of gene therapy for hemophilia, gene editing for sickle cell disease and thalassemia, the evolution of cellular therapy, use of cells, transfusion medicine vs. protein therapy, gene sequencing, immunotherapy, and new targeted drugs. Includes more decision-making algorithms for formulating diagnoses and personalized treatment plans for those highly complex disorders that require individualized approaches. Addresses the effects of aging on hematopoiesis and on the manifestations of a variety of hematologic disorders. Discusses cardio-oncology and its impact on the treatment of patients with hematologic disorders. Presents relevant basic science as background for clinical application in later sections. An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.

For more than 30 years, the highly regarded Secrets Series® has provided students and practitioners in all areas of health care with concise, focused, and engaging resources for quick reference and exam review. Pediatric Hematology & Oncology Secrets, 2nd Edition, offers practical, up-to-date coverage of the full range of essential topics in this dynamic field. This highly regarded resource features the Secrets' popular question-and-answer format that also includes lists, tables, pearls, memory aids, and an easy-to-read style - making inquiry, reference, and review quick, easy, and enjoyable. The proven Secrets Series® format gives you the most return for your time  - succinct, easy to read, engaging, and highly effective.  Fully revised and updated, including discussions of supportive care of children with cancer and psychosocial aspects of care.  New chapters on Precision Medicine and Systems Biology; Health Equity and Disparities in Pediatric and Adolescent/Young Adult Oncology; Transfusion Medicine; Neoplastic Hematopathology; Hemophagocytic Lymphohistiocytosis; and more.  Top 100 Secrets and Key Points boxes provide a fast overview of the secrets you must know for success in practice and on exams. Bulleted lists, mnemonics, practical tips from global leaders in the field - all providing a concise overview of important board-relevant content.  Portable size makes it easy to carry with you for quick reference or review anywhere, anytime.  Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The sixth volume of the book features reviews on these topics: - Immunomodulating Agents in The Treatment of Acute Myeloid Leukemia - Potential Natural Products for Prostate Cancer Management - Inhibition of Key Protein-Protein Interactions by Small Molecules for Cancer Drug Design - Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) For Advanced Hepatocellular Carcinoma - Targeting Cancer Stem Cells: Implications in Health and Disease

Frontiers in Clinical Drug Research - Hematology is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research - Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.The third volume of this series features 6 reviews: -Advances in the understanding and treatment of immune thrombocytopenia-Recent developments in chronic myeloid leukemia biology and treatment-Role of immunomodulatory drugs in the treatment of lymphoid and myeloid malignancies-Pediatric hematological malignancies - clinical manifestation, treatment and follow-up-Novel therapies and immunotherapeutic approaches to treat childhood leukemia-Erythrocyte turnover and erythropoietic patterns in two different experimental mouse models of anemia